Atıf Formatları
Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

Ö. F. TABAK Et Al. , "Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey," 27th Annual Conference of APASl , vol.12, India, pp.181-661, 2018

TABAK, Ö. F. Et Al. 2018. Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey. 27th Annual Conference of APASl , (India), 181-661.

TABAK, Ö. F., YAMAZHAN, T., KURTARAN, B., ESEN, S., ÖZTOPRAK ÇUVALCI, N., ÖNLEN, Y., ... YORUK, G.(2018). Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey . 27th Annual Conference of APASl (pp.181-661). , India

TABAK, ÖMER Et Al. "Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey," 27th Annual Conference of APASl, India, 2018

TABAK, ÖMER F. Et Al. "Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey." 27th Annual Conference of APASl , India, pp.181-661, 2018

TABAK, Ö. F. Et Al. (2018) . "Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey." 27th Annual Conference of APASl , India, pp.181-661.

@conferencepaper{conferencepaper, author={ÖMER FEHMİ TABAK Et Al. }, title={Effectiveness and safety of direct acting antiviral therapies in treatment-experienced chronic hepatitis C infection patients in Turkey}, congress name={27th Annual Conference of APASl}, city={}, country={India}, year={2018}, pages={181-661} }